Pill could make cervical cancer screening more effective
NCT ID NCT06669533
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 32 times
Summary
This study tests whether a medication called misoprostol can help doctors get a clearer view of the cervix during cancer screening. About 420 non-pregnant women aged 25 and older who have a hard-to-see cervix will receive either misoprostol or a placebo. The goal is to see if the pill makes it easier to spot early signs of cervical cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL CANCERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cameroon Baptist Convention Health Core, EtougEbe Baptist Hospital Yaoundé
RECRUITINGYaoundé, Center Region, 2034, Cameroon
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.